$ 12.64
Key Takeaways
Risk factor
Very high price volatility
Profitability factor
Very low or no dividends
About
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its...
Company Valuation
Based on key historical and expected multiples, the stock is slightly overvalued relative to its peers. In particular, the stock is overvalued on P/FCF.
Target Price
The average target price of TXG is 16 and suggests 27% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
